Endometrial cancer classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 11: | Line 11: | ||
** | ** | ||
* Type II | * Type II | ||
{| class="wikitable" | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Type | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Histology | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Prognosis | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Pathogenesis | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Prevalence | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |Type I | |||
| style="background:#F5F5F5;" align="center" + |Endometroid (adenocarcinoma) | |||
| style="background:#F5F5F5;" align="center" + |Favorable (estrogen-responsive) | |||
| style="background:#F5F5F5;" align="center" + |*May arise from atypical hyperplasia// *Linked to unopposed estrogen stimulation | |||
| style="background:#F5F5F5;" align="center" + |80% | |||
|- | |||
| style="background:#DCDCDC;" align="center" + |Type II | |||
| style="background:#F5F5F5;" align="center" + |*Endometroid *Serous *Clear cell *Mucinous *Squamous *Mesonephric *Undifferentiated | |||
| style="background:#F5F5F5;" align="center" + |Typically bad prognosis | |||
| style="background:#F5F5F5;" align="center" + |*Develops from atrophic endometrium </br> *Not linked to hormonally driven pathogenesis | |||
| style="background:#F5F5F5;" align="center" + |15-20% | |||
|} | |||
Revision as of 18:07, 26 November 2018
Endometrial cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial cancer classification On the Web |
American Roentgen Ray Society Images of Endometrial cancer classification |
Risk calculators and risk factors for Endometrial cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
Endometrial cancer may be classified according to histology into either type I comprising 80% of endometrial cancers or type II accounting for around 20%.
Classification
Endometrial cancer may be classified according to histology into 2 types:
- Type I
- Type II
Type | Histology | Prognosis | Pathogenesis | Prevalence |
---|---|---|---|---|
Type I | Endometroid (adenocarcinoma) | Favorable (estrogen-responsive) | *May arise from atypical hyperplasia// *Linked to unopposed estrogen stimulation | 80% |
Type II | *Endometroid *Serous *Clear cell *Mucinous *Squamous *Mesonephric *Undifferentiated | Typically bad prognosis | *Develops from atrophic endometrium *Not linked to hormonally driven pathogenesis |
15-20% |
Classification Based on Pathogenesis
- Endometrial cancers are classified into either type 1 or type 2:[1]
- Type 1 may arise from complex atypical hyperplasia and is pathogenetically linked to unopposed estrogenic stimulation.
- Type 2 develops from atrophic endometrium and is not linked to hormonally driven pathogenesis.
Classification Based on Histopathological Subtype
There are 7 subtypes of endometrial cancer based on histopathology:
- 1. Endometrioid (75%–80%)(The most common endometrial cancer cell type is endometrioid adenocarcinoma, which is composed of malignant glandular epithelial elements)
- Ciliated adenocarcinoma
- Secretory adenocarcinoma
- Papillary or villoglandular
- Adenocarcinoma with squamous differentiation
- Adenoacanthoma
- Adenosquamous (Adenosquamous tumors contain malignant elements of both glandular and squamous epithelium)
- 2. Uterine papillary serous (<10%)
- 3. Mucinous (1%)
- 4. Clear cell (4%)
- 5. Squamous cell (<1%)
- 6. Mixed (10%)
- 7. Undifferentiated